ALLEN, Rodger Anthony,ARMSTRONG, Martin John,CAVAZZANA, Marina,KRACKER, Sven,MCHALE, Duncan Philip,PAYNE, Andrew Charles
申请号：
EPEP2017/061567
公开号：
WO2017/198590A1
申请日:
2017.05.15
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
N-{(R)-1-[8-Chloro-2-(1-oxypyridin-3-yl)-quinolin-3-yl]-2,2,2-trifluoroethyl}-pyrido[3,2-d]pyrimidin-4-ylamine is effective in the treatment and/or prevention of activated phosphoinositide 3-kinase delta syndrome (APDS).La N-{(R)-1-[8-Chloro-2-(1-oxypyridin-3-yl)-quinolin-3-yl]-2,2,2-trifluoroéthyl}-pyrido[3,2-d]pyrimidin-4-ylamine est efficace dans le traitement et/ou la prévention du syndrome de PI3K-delta activée (APDS).
